SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Clinical trials for SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI test aims to match cancer patients with right drugs
Diagnosis Recruiting nowThis study is testing a new diagnostic platform that uses artificial intelligence to analyze small pieces of a patient's tumor. The goal is to predict whether a patient's cancer will respond to immunotherapy drugs before they start treatment. Researchers will compare the AI's pre…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Sponsor: Elephas • Aim: Diagnosis
Last updated Mar 09, 2026 14:25 UTC
-
Blood test could warn of Cancer's return before scans can see it
Knowledge-focused Recruiting nowThis study is testing a blood test to see if it can find tiny leftover cancer cells after treatment for head and neck cancer. Researchers will follow 250 patients for two years to see if a positive blood test predicts if the cancer will return. The study is observational, meaning…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC